Duloxetine: a review of its use in the management of major depressive disorder in older adults.

about

Antidepressant pharmacotherapy in old-age depression-a review and clinical approach.Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder.

P2860

Q38915706-B9D93CE3-4B68-4643-8446-82C815D7CAB3 Q44759185-8D379152-E540-4093-8774-6848061FE7E0

P2860

Duloxetine: a review of its use in the management of major depressive disorder in older adults.

Item

http://www.wikidata.org/entity/Q38067355

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Duloxetine: a review of its us ...... sive disorder in older adults.

@en

type

Item

label

Duloxetine: a review of its us ...... sive disorder in older adults.

@en

prefLabel

Duloxetine: a review of its us ...... sive disorder in older adults.

@en

P1476

Duloxetine: a review of its us ...... sive disorder in older adults.

@en

P2093

Sohita Dhillon

http://www.w3.org/2001/XMLSchema#string

P2860

Serotonin-norepinephrine reuptake inhibitors for pain control: premise and promise

Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label study

Impact of major depression on chronic medical illness

Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II/III trials.

Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials.

Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.

Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.

A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder.

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.

Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression.

P2888

s40266-012-0040-1

P304

59-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40266-012-0040-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23239363

http://www.w3.org/2001/XMLSchema#string

Duloxetine: a review of its use in the management of major depressive disorder in older adults.

about

P2860

P2860

Duloxetine: a review of its use in the management of major depressive disorder in older adults.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698